Latest news from Therapeutic Advances in Hematology on Newswise en-us Copyright 2024 Newswise 115 31 / /images/newswise-logo-rss.gif /articles/efficacy-and-safety-of-mesenchymal-stem-cells-treatment-for-multidrug-resistant-graft-versus-host-disease-after-haploidentical-allogeneic-hematopoietic-stem-cell-transplantation/?sc=rsin /articles/efficacy-and-safety-of-mesenchymal-stem-cells-treatment-for-multidrug-resistant-graft-versus-host-disease-after-haploidentical-allogeneic-hematopoietic-stem-cell-transplantation/?sc=rsin Mon, 24 Jan 2022 08:55:25 EST Purpose: Graft-versus-host disease (GVHD) is an important complication after human leukocyte antigen (HLA) haploidentical donor (HID) hematopoietic stem cell transplantation (HSCT), which may lead to poor prognosis. Our study intends to ... Therapeutic Advances in Hematology